Results 11 to 20 of about 4,858 (141)

Chicago sky blue gel for better visualization of Demodex in patients with Demodex blepharitis [PDF]

open access: yesPeerJ, 2023
Background Demodex blepharitis is a common chronic disease. The number of mites is associated with ocular discomfort. The accurate number derived from well-stained specimens is, hence, in favor of diagnosing, monitoring, and determining treatment ...
Lunla Udomwech   +2 more
doaj   +3 more sources

CLINICAL EFFICACY OF EYELID MARGIN DEEP CLEANING COMBINED WITH INTENSE PULSED LIGHT IN TREATMENT OF DEMODEX BLEPHARITIS [PDF]

open access: yes精准医学杂志, 2023
Objective To investigate the clinical efficacy of eyelid margin deep cleaning combined with intense pulsed light (IPL) in the treatment of patients with demodex blepharitis.
SU Mei, SU Jingjing, CHENG Dan, LIN Baotao, GUO Ping
doaj   +2 more sources

blepharitis treatment with a selenium sulfide-containing ointment: a case report [PDF]

open access: yesTherapeutic Advances in Ophthalmology
Demodex blepharitis is a chronic, progressive condition characterized by inflammation, ocular irritation, and erythema due to an overgrowth of mites in hair follicles and oil glands of the eyelids.
Yair Alster   +2 more
doaj   +2 more sources

Demodex Species and Culturable Microorganism Co-Infestations in Patients with Blepharitis

open access: yesLife, 2023
We aimed to determine the prevalence of Demodex spp. and bacterial infection in patients with blepharitis and also to investigate the relationship between culturable microorganisms and Demodex spp. in this study.
Joanna Pyzia   +6 more
doaj   +2 more sources

Comparison of the Diagnosis and Management of Demodex Blepharitis Between Eye Care Practitioners in India and Australasia - A Survey-Based Comparison [PDF]

open access: yesClin Optom (Auckl)
AimThe primary aim of this study was to compare how eyecare professionals in disparate regions of the world diagnose and manage Demodex blepharitis.
Purslow, Christine   +5 more
core   +3 more sources

Global Trends in Studies on the Presence of Demodex spp in Patients Diagnosed with Blepharitis

open access: yesJournal of Arthropod-Borne Diseases
Background: The main objective of this study is to review publications on the presence of Demodex spp. in patients diagnosed with blepharitis worldwide and to analyse the trends and groups in this field. Methods: This bibliometric study was conducted
Rahmi Yildiz, Milad Afşar, Sadi Elasan
doaj   +2 more sources

Efficacy and Safety of Lotilaner Ophthalmic Solution 0.25% in Demodex Blepharitis: A Systematic Review [PDF]

open access: yesHCA Healthc J Med
Description Demodex blepharitis is a chronic eyelid inflammation caused by Demodex mites, which are ubiquitous skin parasites. Lotilaner, a newly United States Food and Drug Administration (FDA)-approved drug, is an antiparasitic agent that selectively ...
Fabara, Stephanie P   +3 more
core   +2 more sources

Impact of lotilaner ophthalmic solution 0.25% on disease severity in patients with Demodex blepharitis and meibomian gland disease [PDF]

open access: yesFrontiers in Medicine
PurposeTo evaluate the impact of lotilaner ophthalmic solution, 0.25%, compared to vehicle, on disease severity in patients with Demodex blepharitis and meibomian gland disease.MethodsThis post-hoc analysis pooled data from two prospective, randomized ...
Bridgitte Shen Lee   +4 more
doaj   +2 more sources

Comparison of the Diagnosis and Management of Demodex Blepharitis Between Eye Care Practitioners in India and Australasia – A Survey-Based Comparison [PDF]

open access: yesClinical Optometry
Nikhil Sharma,1 Eilidh Martin,1 Edward Ian Pearce,1 Suzanne Hagan,1 Christine Purslow,2 Jennifer P Craig3 1Glasgow Caledonian University, Glasgow, Scotland, UK; 2Christine Purslow – School of Optometry and Vision Sciences, Cardiff University, Cardiff ...
Sharma N   +5 more
doaj   +1 more source

Demodex Infestation in Patients With Atopic Dermatitis Treated With Dupilumab: A Case–Control Study [PDF]

open access: yesThe Journal of Dermatology, Volume 53, Issue 9, Page 1261-1266, September 2026.
ABSTRACT Atopic dermatitis (AD) is a chronic inflammatory skin disease in which dupilumab, an interleukin‐4 receptor alpha antagonist, has become a cornerstone therapy for moderate‐to‐severe disease. However, persistent facial and neck erythema and related symptoms have been increasingly reported during dupilumab treatment, and the underlying ...
Pinar Dursun   +2 more
wiley   +2 more sources

Home - About - Disclaimer - Privacy